查詢結果分析
相關文獻
- Antitumor Anthraquinone Analogues for Multidrug Resistant Tumor Cells
- The Effects of Pesticides Chlordane, Dieldrin and Endosulfan on the Growth of Human Breast Cancer Cell Lines MCF-7 and SK-BR-3
- Use of Cremophor EL as a MDR Reversing Agent to Enhance Intestinal Absorption of Epirubicin in Everted Gut Sacs of Rats and Human Intestinal Epithelial Caco-2 Cell Layers
- 長期葉酸消耗對人類肝癌細胞株HepG2之細胞生長繁殖及形態變化的影響
- 三株卵巢癌細胞株變異生長因子之表現
- 建立Acid Phosphatase酵素分析方法大量篩選天然物之抗癌藥
- 乙型轉型因子對於肝癌細胞死亡的調控與機制之研究
- The Combined Effect of Colchicine and Radiation on Human Hepatoma HA22T/VGH Cells
- 乳癌細胞MCF-7感染反義第一型類胰島素生長因子(IGF-I)基因生長速率降低機制的探討
- A Toxin Conjugate Containing Transforming Growth Factor-α and Ricin a Specifically Inhibits Growth of A431 Human Epidermoid Cancer Cells
頁籤選單縮合
| 題 名 | Antitumor Anthraquinone Analogues for Multidrug Resistant Tumor Cells=抗癌蒽醌類衍生物對癌細胞的多重抗藥性 |
|---|---|
| 作 者 | 黃旭山; | 書刊名 | Journal of Medical Sciences |
| 卷 期 | 26:1 民95.02 |
| 頁 次 | 頁1-4 |
| 分類號 | 414.5 |
| 關鍵詞 | 蒽醌類衍生物; 癌細胞; Anthraquinone; Antibiotics; Cancer; Chemotherapy; Multidrug resistance; |
| 語 文 | 英文(English) |
| 英文摘要 | The discovery of new compounds with antitumor activity has become one of the most important goals in medicinal chemistry. One interesting group of chemotherapeutic agents used in cancer therapy comprises molecules that interact with DNA. Research in this area has revealed a range of DNA-recognizing molecules that act as antitumor agents, including groove binders, alkylating and intercalator compounds. DNA intercalators (molecules that intercalate between DNA base pairs) have attracted particular attention because of their antitumor activity. For example, a number of acridine and anthracycline derivatives are excellent DNA intercalators that are now on the market as chemotherapeutic agents. Commercially available acridine and anthracycline derivatives have been widely studied from a variety of viewpoints, such as physico-chemical properties, structural requirements, synthesis, and biological activity. However, the clinical application of these and other compounds of the same class have encountered problems such as multidrun resistance (MDR) and secondary and/or side effects. These shortcomings have motivated the search for new compounds to be used either in place of, or in conjunction with, the existing compounds. Unfortunately, the results of this search have not met expectations. Most candidate DNA intercalating compounds tested for use as anticancer agents have shown little or no biological activity. Research in this area has not been without benefits, for it has produced much information about the synthesis and antitumor properties of hundreds of compounds tested on diverse tumor cell lines. This review analyzes the structural and biological considerations relevant to the use of some anthraquinone analogues as anticancer agents, with the emphasis on the relationship between structure and acitvity. |
本系統中英文摘要資訊取自各篇刊載內容。